Tianjin Pharmaceutical Da Ren Tang Group Corporation Company Description

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China.

It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs.

The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022.

The company was founded in 1915 and is based in Tianjin, the People’s Republic of China.

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Country	China
Founded	1915
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	4,619
CEO	Lei Wang

Contact Details

Address: No. 17, Baidi Road Tianjin, 300193 China
Phone	86 22 2702 0892
Website	jydrt.com.cn

Stock Details

Ticker Symbol	600329
Exchange	Shanghai Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE000001808
SIC Code	2834

Key Executives

Name	Position
Lei Wang	Chairman of the Board
Jian Ma	Chief Financial Officer
Hong Zhou	Deputy GM, Chief Engineer and Executive Director
Min Guo	Executive Director
Yu Zhang	Chief Manufacturing Officer
Mingjie Shang	Executive Director
Yan Jiao	Secretary to the Board of Directors